Compounds > cilostazol

cilostazol and transforming growth factor beta

cilostazol has been researched along with transforming growth factor beta in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oshiro, Y; Shimabukuro, M; Shimajiri, Y; Takasu, N; Tohma, T; Yamakawa, M1
Cho, WH; Choi, HS; Hur, SH; Jung, GS; Kim, BW; Kim, HS; Kim, HT; Kim, JG; Kim, MK; Lee, HJ; Lee, IK; Lee, KM; Lee, KU; Lim, JO; Park, KG1
Chen, CC; Chen, HC; Lee, HJ; Lee, WC; Lin, PY; Ou, TT; Wang, CY; Wang, J; Wen, MC1
Abdel Kawy, HS1
Dold, S; Kollmar, O; Menger, MD; Moussavian, MR; Müller, S; Scheuer, C; Schilling, MK; von Heesen, M1
Daugherty, A; Davis, FM; Lu, HS1

Reviews

1 review(s) available for cilostazol and transforming growth factor beta

ArticleYear
Updates of Recent Aortic Aneurysm Research.
    Arteriosclerosis, thrombosis, and vascular biology, 2019, Volume: 39, Issue:3

    Topics: Adaptor Proteins, Signal Transducing; Aged; Aged, 80 and over; Animals; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortitis; Cilostazol; Disease Models, Animal; Female; Genetic Predisposition to Disease; Humans; Macrophage Activation; Male; Mice; Risk Factors; Sex Factors; Transforming Growth Factor beta

2019

Other Studies

5 other study(ies) available for cilostazol and transforming growth factor beta

ArticleYear
Cilostazol, a phosphodiesterase inhibitor, reduces microalbuminuria in the insulin-resistant Otsuka Long-Evans Tokushima Fatty rat.
    Metabolism: clinical and experimental, 2004, Volume: 53, Issue:11

    Topics: Albuminuria; Animals; Blood Glucose; Cilostazol; Collagen Type I; Diabetic Nephropathies; Fibronectins; Hyperinsulinism; Insulin Resistance; Kidney Glomerulus; Male; Phosphodiesterase Inhibitors; Rats; Rats, Inbred OLETF; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1

2004
Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury.
    Atherosclerosis, 2009, Volume: 207, Issue:2

    Topics: Angioplasty, Balloon; Angiotensin II; Animals; Binding Sites; Blood Glucose; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Cells, Cultured; Cilostazol; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hyperplasia; JNK Mitogen-Activated Protein Kinases; Male; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad3 Protein; Tetrazoles; Transcriptional Activation; Transforming Growth Factor beta; Tunica Intima

2009
Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF-Beta and NF-kappaB.
    Bioscience, biotechnology, and biochemistry, 2010, Volume: 74, Issue:7

    Topics: Animals; Blood Glucose; Body Weight; Cilostazol; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression Regulation; Kidney; Lipid Metabolism; Male; NF-kappa B; Organ Size; Oxidative Stress; Rats; Rats, Sprague-Dawley; Serum Albumin; Tetrazoles; Transforming Growth Factor beta

2010
Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats.
    European journal of pharmacology, 2015, Apr-05, Volume: 752

    Topics: Actins; Animals; Cholestasis; Cilostazol; Common Bile Duct; Dose-Response Relationship, Drug; Hemoglobins; Ligation; Liver; Liver Cirrhosis; Male; Neovascularization, Pathologic; Portal Pressure; Proline; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2015
Cilostazol improves hepatic blood perfusion, microcirculation, and liver regeneration after major hepatectomy in rats.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2015, Volume: 21, Issue:6

    Topics: Animals; Apoptosis; Bile; Cilostazol; Drug Evaluation, Preclinical; Female; Liver; Liver Circulation; Liver Failure; Liver Regeneration; Models, Animal; Phosphodiesterase 3 Inhibitors; Rats, Sprague-Dawley; Tetrazoles; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A

2015